France· FR:68803824
PAZOPANIB ACCORD 400 mg, comprimé pelliculé
A medicinal product containing chlorhydrate de pazopanib, registered in France by ACCORD HEALTHCARE FRANCE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE PAZOPANIB
- Manufacturer
- ACCORD HEALTHCARE FRANCE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip1334009302824581 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s)EUR 481.37
- cip1334009302824721 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 60 comprimé(s)EUR 937.82
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate de pazopanib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPAZOPANIB ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- PolandPazopanib AccordAccord Healthcare Polska Sp. z o.o.
- FinlandPazopanib AccordAccord Healthcare B.V.
- NetherlandsPazopanib Accord 400 mg filmomhulde tablettenAccord Healthcare B.V.
- SwedenPazopanib Accord 400 mg Filmdragerad tablettAccord Healthcare B.V.
- IrelandPazopanib Accord 400 mg film-coated tabletsAccord Healthcare Ireland Ltd.
- SpainPAZOPANIB ACCORD 400 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGAccord Healthcare S.L.U.
- BelgiumPazopanib Accord 400 mgAccord Healthcare
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Pazopanib Devatis
- Belgium · Pazopanib Accord, Pazopanib Eg
- Bulgaria · Алуниб, Пазопаниб G.L. Pharma
- Cyprus · Pazopanib Sapiens, Pazorem
- Czechia · Pazopanib Accord, Pazopanib Sandoz
- Germany · Pazopanib Al, Pazopanib Beta
- Denmark · Pazopanib Accord, Pazopanib Glenmark
- Estonia · Pazopanib Accord, Pazopanib Teva
- Spain · Pazopanib Accord, Pazopanib Dr. Reddys
- Finland · Pazopanib Accord, Pazopanib Glenmark
- United Kingdom (Northern Ireland) · Pazopanib Accord, Pazopanib Accord Healthcare
- Greece · Pazopanib Accord, Pazopanib Stada
- Croatia · Pazopanib Accord, Pazopanib Frontier
- Hungary · Pazopanib Accord, Pazopanib G.L. Pharma
- Ireland · Pazopanib Accord, Pazopanib Reddy
- Iceland · Pazopanib Adalvo, Pazopanib Stada
- Italy · Pazopanib Accord, Pazopanib Dr. Reddy’s
- Liechtenstein · Votrient
- Lithuania · Pazopanib Accord, Pazopanib Auxilia
- Luxembourg · Pazopanib Eg, Pazopanib Pazopanib Eg
- Latvia · Pazopanib Accord, Pazopanib Teva
- Malta · Pazopanib Pharmacare, Pazopanib Pharos
- Netherlands · Pazopanib Accord, Pazopanib Cf
- Norway · Pazopanib Accord, Pazopanib Glenmark
- Poland · Pazopanib Accord, Pazopanib Glenmark
- Portugal · Pazopanib Accord, Pazopanib Bluepharma
- Romania · Pazopanib Accord, Pazopanib Dr. Reddys
- Sweden · Pazopanib Accord, Pazopanib Glenmark
- Slovenia · Pazopanib Accord, Pazopanib Teva
- Slovakia · Pazopanib Accord, Pazopanib G.L. Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/371ce6aa-51e6-4eaf-ad3a-c799c100699a GET /v1/drugs/371ce6aa-51e6-4eaf-ad3a-c799c100699a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68803824",
"date_amm": "2023-11-17",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "CHLORHYDRATE DE PAZOPANIB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate de pazopanib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.